Diabetes Remote Monitoring
Research Objectives:
The Center for Connected Health and MGH Ambulatory Practice of the Future have formed a partnership to test and assess a treatment approach for Type 2 Diabetics. The purpose of this program is to facilitate the remote monitoring of patients with Type 2 diabetes, in coordination with Bulfinch Medical Group, and help the patients monitor and understand their blood glucose levels and trends over time.
Drivers:
Diabetes is a chronic illness that affects the daily lives of more than 20 million adults and children in the United States – and this number is growing rapidly. People with diabetes do not produce or properly use insulin, a hormone that helps to convert sugar, starches and other food into energy, which causes glucose to build up in the blood instead of going into cells. High levels of sugar in the blood over time can lead to serious health complications. Understanding how to keep blood glucose (sugar) levels within normal range and minimize fluctuations throughout the day is essential to managing Type 2 Diabetes and mitigating the onset of related problems such as eye, nerve, kidney and blood vessel damage (American Diabetic Association).
Program Overview:
The Center for Connected Health and MGH Ambulatory Practice of the Future will offer a system to help patients collect and transmit their blood sugar readings. This allows both patients and care providers improved opportunities for managing blood sugar levels.
Patients will send their blood glucose measurements via a communications gateway linked through a telephone line. They will have the option to access their blood glucose details and understand their glucose trends from the convenience of their home. Their providers have improved information about their patients’ blood glucose readings and daily logs to help understand and manage patient care plans outside of scheduled office visits.
This new approach for patient self-management and care team remote monitoring creates pathways of communication and collaboration to improve “real time” management of diabetes.